Status:
UNKNOWN
Retinal Vascular Reactivity in Subjects With Newly Diagnosed Glaucoma Before and After Selective Laser Trabeculoplasty
Lead Sponsor:
University of Toronto
Collaborating Sponsors:
University of Western Ontario, Canada
Conditions:
Glaucoma
Eligibility:
All Genders
40-75 years
Brief Summary
The purpose of this study is to assess retinal blood flow and vascular reactivity in patients with newly diagnosed primary open angle glaucoma pre- and post-primary Selective Laser Trabeculoplasty(SLT...
Detailed Description
We previously found that vascular reactivity improved after short term treatment with dorzolamide drops. It is not clear whether this improvement was a direct effect of the medication or secondary eff...
Eligibility Criteria
Inclusion
- Age 40-75 years (Male or Female)
- Best corrected visual acuity of at least 20/40
- No previous treatment for glaucoma
- Ametropia less than ±6.0 DS and ±2.5 DC)
- Non-smoker
- No cardiovascular/respiratory disorders
Exclusion
- Past history of diabetes and cerebrovascular accident
- Vascular occlusive disease affecting the ocular circulation such as: diabetic retinopathy, retinal vein occlusion and retinal artery occlusion
- Previous intraocular surgery
- Ocular media opacities limiting the use of the imaging tests
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01209975
Start Date
November 1 2008
Last Update
September 28 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T2S8